Not sure if this has been discussed yet but this was related by admiral on their report..
Finasteride (ALM12845) - androgenetic alopecia
On the 26th of September the Marketing Authorization Application (MAA) was submitted for Finasteride.
The product is a cutaneous spray, solution has been demonstrated to be safe and effective in the topical treatment of adult men with male pattern hair loss (androgenetic alopecia, Androgenetic Alopecia).
The product is subject to medical prescription. First national phase approval is estimated in 2020 or early 2021 in Europe.
Finasteride (ALM12845) - androgenetic alopecia
On the 26th of September the Marketing Authorization Application (MAA) was submitted for Finasteride.
The product is a cutaneous spray, solution has been demonstrated to be safe and effective in the topical treatment of adult men with male pattern hair loss (androgenetic alopecia, Androgenetic Alopecia).
The product is subject to medical prescription. First national phase approval is estimated in 2020 or early 2021 in Europe.